From this analysis, Figure 5C showed four individual chemokines with significant change in COVID‐19 (CCL4, CCL‐11, CCL‐20 and CCL‐28), which could determine the immune status of the respiratory tract with two chemokines being mucosal (CCL20) and columnar epithelium (CCL11) specific. This evidence concerns the gene CCL20 and COVID-19.